Cargando…

Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study

BACKGROUND: Congenital scoliosis (CS) is characterized by vertebral malformations. The precise etiology of CS is not fully defined. A compound inheritance of TBX6 was identified in 10% of patients with CS in Han Chinese and formed a distinguishable subtype named TBX6-associated congenital scoliosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenyan, Yao, Ziming, Guo, Ruolan, Li, Haichong, Zhao, Shuang, Li, Wei, Zhang, Xuejun, Hao, Chanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403053/
https://www.ncbi.nlm.nih.gov/pubmed/36035411
http://dx.doi.org/10.3389/fmed.2022.941468
_version_ 1784773284755144704
author Zhang, Wenyan
Yao, Ziming
Guo, Ruolan
Li, Haichong
Zhao, Shuang
Li, Wei
Zhang, Xuejun
Hao, Chanjuan
author_facet Zhang, Wenyan
Yao, Ziming
Guo, Ruolan
Li, Haichong
Zhao, Shuang
Li, Wei
Zhang, Xuejun
Hao, Chanjuan
author_sort Zhang, Wenyan
collection PubMed
description BACKGROUND: Congenital scoliosis (CS) is characterized by vertebral malformations. The precise etiology of CS is not fully defined. A compound inheritance of TBX6 was identified in 10% of patients with CS in Han Chinese and formed a distinguishable subtype named TBX6-associated congenital scoliosis (TACS). METHODS: To investigate the variants and risk haplotype of TBX6, we recruited 121 patients with CS at Beijing Children’s Hospital. We collected the clinical characteristics and surgical treatment options and followed their postoperative prognoses. RESULTS: Eight patients (6.6%) were molecularly diagnosed with TACS and carried the previously defined pathogenic TBX6 compound heterozygous variants. All the eight patients with TACS had the typical TACS clinical feature of hemivertebrae in the lower part of the spine. These patients received posterior hemivertebra resection combined with segmental fusion. Follow-ups revealed satisfactory correction without postoperative complications. CONCLUSION: We observed a 6.6% prevalence of TACS in our CS cohort. Follow-ups further highlighted that surgical treatment of hemivertebra resection combined with segmental fusion performed well with prognosis for patients with TACS. This could provide valuable information for CS individuals with compound heterozygosity in TBX6.
format Online
Article
Text
id pubmed-9403053
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94030532022-08-26 Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study Zhang, Wenyan Yao, Ziming Guo, Ruolan Li, Haichong Zhao, Shuang Li, Wei Zhang, Xuejun Hao, Chanjuan Front Med (Lausanne) Medicine BACKGROUND: Congenital scoliosis (CS) is characterized by vertebral malformations. The precise etiology of CS is not fully defined. A compound inheritance of TBX6 was identified in 10% of patients with CS in Han Chinese and formed a distinguishable subtype named TBX6-associated congenital scoliosis (TACS). METHODS: To investigate the variants and risk haplotype of TBX6, we recruited 121 patients with CS at Beijing Children’s Hospital. We collected the clinical characteristics and surgical treatment options and followed their postoperative prognoses. RESULTS: Eight patients (6.6%) were molecularly diagnosed with TACS and carried the previously defined pathogenic TBX6 compound heterozygous variants. All the eight patients with TACS had the typical TACS clinical feature of hemivertebrae in the lower part of the spine. These patients received posterior hemivertebra resection combined with segmental fusion. Follow-ups revealed satisfactory correction without postoperative complications. CONCLUSION: We observed a 6.6% prevalence of TACS in our CS cohort. Follow-ups further highlighted that surgical treatment of hemivertebra resection combined with segmental fusion performed well with prognosis for patients with TACS. This could provide valuable information for CS individuals with compound heterozygosity in TBX6. Frontiers Media S.A. 2022-08-11 /pmc/articles/PMC9403053/ /pubmed/36035411 http://dx.doi.org/10.3389/fmed.2022.941468 Text en Copyright © 2022 Zhang, Yao, Guo, Li, Zhao, Li, Zhang and Hao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Zhang, Wenyan
Yao, Ziming
Guo, Ruolan
Li, Haichong
Zhao, Shuang
Li, Wei
Zhang, Xuejun
Hao, Chanjuan
Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
title Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
title_full Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
title_fullStr Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
title_full_unstemmed Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
title_short Molecular identification of T-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: A single-center study
title_sort molecular identification of t-box transcription factor 6 and prognostic assessment in patients with congenital scoliosis: a single-center study
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403053/
https://www.ncbi.nlm.nih.gov/pubmed/36035411
http://dx.doi.org/10.3389/fmed.2022.941468
work_keys_str_mv AT zhangwenyan molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT yaoziming molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT guoruolan molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT lihaichong molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT zhaoshuang molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT liwei molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT zhangxuejun molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy
AT haochanjuan molecularidentificationoftboxtranscriptionfactor6andprognosticassessmentinpatientswithcongenitalscoliosisasinglecenterstudy